DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,535.00
-100.00 (-2.75%)
At close: Jan 30, 2026

DK Life Science Revenue

DK Life Science had revenue of 29.44B KRW in the quarter ending September 30, 2025, a decrease of -9.17%. This brings the company's revenue in the last twelve months to 131.17B, up 0.95% year-over-year. In the year 2024, DK Life Science had annual revenue of 131.82B with 9.70% growth.

Revenue (ttm)
131.17B
Revenue Growth
+0.95%
P/S Ratio
0.86
Revenue / Employee
1.31B
Employees
100
Market Cap
113.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024131.82B11.65B9.70%
Dec 31, 2023120.16B12.93B12.05%
Dec 31, 2022107.23B4.57B4.45%
Dec 31, 2021102.67B-6.91B-6.31%
Dec 31, 2020109.58B10.97B11.12%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4.56T
Celltrion3.90T
Jeil Pharma Holdings707.15B
ALTEOGEN202.18B
CKD Bio159.93B
ABL Bio88.44B
Aprogen Biologics74.91B
Enzychem Lifesciences72.17B
Revenue Rankings